Results
254
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
254 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
NVDA | US$117.97 | -12.6% | 150.6% | US$3.1t | US$136.60 | PE68.1x | E23.2% | 0.03% | Semiconductors | ||
SRPT | US$146.90 | -1.6% | 38.7% | US$14.1b | US$198.28 | PE821.8x | E39.9% | n/a | Pharmaceuticals & Biotech | ||
ARES | US$143.72 | 3.6% | 40.8% | US$46.3b | US$151.50 | PE66.7x | E29.0% | 2.6% | Diversified Financials | ||
NU | US$13.22 | 0.08% | 73.5% | US$65.0b | US$13.55 | PB9.3x | E27.4% | n/a | Banks | ||
SGEN | US$228.74 | 4.5% | 76.5% | US$43.2b | US$228.91 | PS18.8x | E71.8% | n/a | Pharmaceuticals & Biotech | ||
PDD | US$131.82 | -4.5% | 75.2% | US$188.7b | US$207.21 | PE16.6x | E21.4% | n/a | Retail | ||
CG | US$45.47 | 9.6% | 27.3% | US$16.7b | US$48.05 | PS7.4x | E23.6% | 3.1% | Diversified Financials | ||
SMCI | US$816.31 | -9.3% | 168.8% | US$51.4b | US$1,035.32 | PE45.6x | E40.2% | n/a | Tech | ||
SYM | US$39.64 | 8.6% | -18.6% | US$24.2b | US$55.79 | PS2.7x | E131.1% | n/a | Capital Goods | ||
OWL | US$18.78 | 9.0% | 53.3% | US$26.2b | US$20.92 | PE137.5x | E90.4% | 3.8% | Diversified Financials | ||
LEGN | US$55.00 | 16.2% | -21.9% | US$10.2b | US$82.37 | PS29.2x | E63.7% | n/a | Pharmaceuticals & Biotech | ||
RYAN | US$58.39 | 4.0% | 29.3% | US$15.2b | US$60.08 | PE109.3x | E49.2% | 0.8% | Insurance | ||
SPOT | US$294.74 | -3.4% | 63.9% | US$59.4b | US$354.55 | PS3.9x | E40.2% | n/a | Media | ||
TER | US$152.35 | -4.3% | 32.1% | US$25.4b | US$144.02 | PE55.4x | E23.7% | 0.3% | Semiconductors | ||
ZS | US$194.93 | -1.2% | 21.0% | US$30.7b | US$230.08 | PS14.5x | E50.9% | n/a | Software | ||
NTNX | US$48.25 | -18.5% | 63.7% | US$12.4b | US$74.54 | PS5.7x | E82.8% | n/a | Software | ||
CHK | US$82.05 | -1.2% | -0.1% | US$10.9b | US$104.50 | PE10.2x | E36.5% | 3.0% | Energy | ||
ELF | US$170.70 | -14.4% | 50.2% | US$10.7b | US$218.08 | PE75.4x | E21.6% | n/a | Household | ||
VRT | US$81.78 | -13.1% | 206.4% | US$33.6b | US$103.26 | PE75.8x | E30.3% | 0.1% | Capital Goods | ||
PTC | US$179.77 | 1.7% | 22.6% | US$22.0b | US$203.05 | PE74.8x | E22.8% | n/a | Software | ||
ALNY | US$240.02 | -6.9% | 16.9% | US$31.6b | US$254.65 | PS15.2x | E63.5% | n/a | Pharmaceuticals & Biotech | ||
HUBS | US$480.36 | -2.4% | -15.5% | US$24.9b | US$659.28 | PS10.7x | E59.6% | n/a | Software | ||
TEAM | US$178.92 | 2.6% | -5.1% | US$47.7b | US$238.30 | PS11.2x | E45.4% | n/a | Software | ||
CRWD | US$354.94 | -5.2% | 125.2% | US$89.8b | US$403.00 | PE656.1x | E34.8% | n/a | Software |